Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HM13 intronic transcript 1 (HM13-IT1)
- Target
- HM13-IT1
- Molecular classification
- Long non-coding RNA (lncRNA), specifically an intronic transcript, Does not fall into classes such as "Receptor," "Enzyme," "Transporter," etc.
01
Overview
HM13 intronic transcript 1 (HM13-IT1) is a long non-coding RNA gene, transcribed from an intronic region within the human HM13 (histocompatibility minor 13) gene. Like other intronic lncRNAs, HM13-IT1 does not code for a protein, and its precise molecular function, disease relevance, or clinical significance remains unclear. Such transcripts may influence the expression or stability of their host gene (here, HM13) or participate in broader regulatory RNA networks. There is currently no established role for HM13-IT1 as a therapeutic target, disease marker, or risk factor.
02
Mechanism of action
Not applicable—no drugs or experimental compounds are known to act on HM13-IT1.
03
Biological functions
Potential regulatory RNA: Like other intronic transcripts, it may play a role in post-transcriptional gene expression regulation or in regulating the alternative splicing or stabilization of the HM13 messenger RNANo specific or unique biological function for HM13-IT1 has been described in the literature or databases beyond the general properties of intronic lncRNAs
04
Disease associations
Unknown/Other: No specific disease association or pathophysiological role has been described for HM13-IT1The parent gene, HM13, is implicated in cancer and immune-related processes, but there is no specific evidence that HM13-IT1 itself plays a disease-driving role
Beyond the preview
Go deeper on HM13 intronic transcript 1 (HM13-IT1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HM13 intronic transcript 1 (HM13-IT1).